Suppr超能文献

在进行性核上性麻痹的重复神经心理状态评估电池中认知能力下降。

Cognitive decline on the Repeatable Battery for the Assessment of Neuropsychological Status in progressive supranuclear palsy.

机构信息

Department of Neurology, University of Utah, Salt Lake City, UT, USA.

Department of Neurology, Loyola University Medical Center, Maywood, IL, USA.

出版信息

Clin Neuropsychol. 2020 Apr;34(3):529-540. doi: 10.1080/13854046.2019.1670865. Epub 2019 Sep 27.

Abstract

Progressive supranuclear palsy (PSP) is associated with a variety of cognitive deficits, but few studies have reported on its cognitive trajectory across time, especially on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Two hundred twenty participants diagnosed with Richardson's syndrome of PSP (PSP-RS) were evaluated with the RBANS at baseline, six months, and one year with alternate forms. When using dependent -tests, significant declines were observed on all Indexes of the RBANS from baseline to six months (ps < 0.01). Between six months and one year, significant declines were observed on three Indexes of the RBANS (ps < 0.05). Using existing regression-based change formulae from cognitively intact older adults, these participants with PSP showed significant decline on all RBANS Indexes (ps < 0.01) across one year. Finally, new regression-based change formulae were developed on this sample of individuals with PSP-RS to more precisely evaluate cognitive change in this condition. In this large, longitudinal cohort of participants with PSP-RS, many (but not all) showed notable cognitive decline across six months and one year on the RBANS. The different methods of examining change across time yielded different results, with regression-based methods appearing to more accurately capture decline in this sample. These findings are expected to allow clinicians to more accurately evaluate cognitive trajectories in patients with PSP, as well as make better estimates of prognosis and offer more appropriate treatment recommendations. Such findings are also expected to inform clinical trials as to the changes in cognitive outcomes with this neurological condition.

摘要

进行性核上性麻痹(PSP)与多种认知缺陷有关,但很少有研究报告其随时间的认知轨迹,特别是在重复性成套神经心理状态评估量表(RBANS)上。220 名被诊断为 PSP 的 Richardson 综合征(PSP-RS)的参与者在基线、6 个月和 1 年时使用交替形式接受 RBANS 评估。使用依赖检验,从基线到 6 个月时,RBANS 的所有指数都观察到显著下降(ps<0.01)。在 6 个月到 1 年之间,RBANS 的三个指数观察到显著下降(ps<0.05)。使用认知正常的老年人的现有基于回归的变化公式,这些 PSP 患者在所有 RBANS 指数上都表现出显著下降(ps<0.01),持续一年。最后,针对 PSP-RS 个体的这一样本开发了新的基于回归的变化公式,以更准确地评估这种情况下的认知变化。在这个 PSP-RS 的大型纵向队列中,许多(但不是全部)参与者在 RBANS 上显示出在 6 个月和 1 年内明显的认知下降。随着时间推移检查变化的不同方法产生了不同的结果,基于回归的方法似乎更准确地捕捉到了该样本中的下降。这些发现有望使临床医生更准确地评估 PSP 患者的认知轨迹,并对预后做出更好的估计,提供更合适的治疗建议。这些发现还将为临床试验提供信息,了解这种神经状况下认知结果的变化。

相似文献

1
Cognitive decline on the Repeatable Battery for the Assessment of Neuropsychological Status in progressive supranuclear palsy.
Clin Neuropsychol. 2020 Apr;34(3):529-540. doi: 10.1080/13854046.2019.1670865. Epub 2019 Sep 27.
2
Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.
J Clin Exp Neuropsychol. 2019 Jul;41(5):469-475. doi: 10.1080/13803395.2019.1572073. Epub 2019 Feb 4.
3
Development of a cognitive composite for measuring change in progressive supranuclear palsy.
Parkinsonism Relat Disord. 2021 Nov;92:94-100. doi: 10.1016/j.parkreldis.2021.10.007. Epub 2021 Oct 12.
4
Motor, cognitive and behavioral differences in MDS PSP phenotypes.
J Neurol. 2019 Jul;266(7):1727-1735. doi: 10.1007/s00415-019-09324-x. Epub 2019 Apr 15.
6
Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
Parkinsonism Relat Disord. 2017 Dec;45:50-56. doi: 10.1016/j.parkreldis.2017.10.002. Epub 2017 Oct 6.
7
Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials.
Parkinsonism Relat Disord. 2016 Jul;28:41-48. doi: 10.1016/j.parkreldis.2016.04.014. Epub 2016 Apr 18.
9
Rate of decline in progressive supranuclear palsy.
Mov Disord. 2014 Apr;29(4):463-8. doi: 10.1002/mds.25843. Epub 2014 Feb 24.
10
Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
J Neural Transm (Vienna). 2019 Nov;126(11):1437-1445. doi: 10.1007/s00702-019-02065-1. Epub 2019 Aug 20.

引用本文的文献

2
Biomarkers of disease progression in progressive supranuclear palsy for use in clinical trials.
Brain Commun. 2025 Jan 16;7(1):fcaf022. doi: 10.1093/braincomms/fcaf022. eCollection 2025.
3
Montreal cognitive assessment as a cognitive outcome measure in progressive supranuclear palsy.
Front Neurol. 2024 Dec 4;15:1501206. doi: 10.3389/fneur.2024.1501206. eCollection 2024.
4
Rapid Cognitive Deterioration in Progressive Supranuclear Palsy: A 1-Year Follow-Up Study.
Mov Disord Clin Pract. 2025 Apr;12(4):475-483. doi: 10.1002/mdc3.14315. Epub 2024 Dec 27.
5
Cognitive impairment in Parkinson's disease and other parkinsonian syndromes.
J Neural Transm (Vienna). 2025 Mar;132(3):341-355. doi: 10.1007/s00702-024-02865-0. Epub 2024 Nov 30.
6
Alexithymia is associated with insomnia in Chinese patients with schizophrenia.
Front Psychiatry. 2023 Dec 15;14:1252763. doi: 10.3389/fpsyt.2023.1252763. eCollection 2023.
7
Subjective cognitive complaints in patients with progressive supranuclear palsy.
Front Neurol. 2023 Dec 14;14:1326571. doi: 10.3389/fneur.2023.1326571. eCollection 2023.
8
Recall and recognition subtests of the repeatable battery for the assessment of neuropsychological status and their relationship to biomarkers of Alzheimer's disease.
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2023 Sep-Nov;30(6):885-902. doi: 10.1080/13825585.2022.2124229. Epub 2022 Sep 15.
9
Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.
J Neurol. 2021 Sep;268(9):3400-3408. doi: 10.1007/s00415-021-10511-y. Epub 2021 Mar 11.

本文引用的文献

1
Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.
J Clin Exp Neuropsychol. 2019 Jul;41(5):469-475. doi: 10.1080/13803395.2019.1572073. Epub 2019 Feb 4.
2
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.
Lancet Neurol. 2017 Jul;16(7):552-563. doi: 10.1016/S1474-4422(17)30157-6. Epub 2017 Jun 13.
3
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.
Mov Disord. 2017 Jun;32(6):853-864. doi: 10.1002/mds.26987. Epub 2017 May 3.
4
Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials.
Parkinsonism Relat Disord. 2016 Jul;28:41-48. doi: 10.1016/j.parkreldis.2016.04.014. Epub 2016 Apr 18.
6
Norms and reliability for the Spanish version of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Form A.
J Clin Exp Neuropsychol. 2014;36(10):1023-30. doi: 10.1080/13803395.2014.965664. Epub 2014 Nov 3.
7
Normative data for the repeatable battery for the assessment of neuropsychological status in elderly Chinese.
Arch Clin Neuropsychol. 2014 Aug;29(5):442-55. doi: 10.1093/arclin/acu023. Epub 2014 Jun 5.
8
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial.
Lancet Neurol. 2014 Jul;13(7):676-85. doi: 10.1016/S1474-4422(14)70088-2. Epub 2014 May 27.
9
Rate of decline in progressive supranuclear palsy.
Mov Disord. 2014 Apr;29(4):463-8. doi: 10.1002/mds.25843. Epub 2014 Feb 24.
10
A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy.
PLoS One. 2013 Sep 10;8(9):e74486. doi: 10.1371/journal.pone.0074486. eCollection 2013.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验